DNA glycosylase dysregulation is implicated in carcinogenesis
and
therapeutic resistance of cancers. Thus, various DNA-based detection
platforms have been developed by leveraging the base excision activity
of DNA glycosylases. However, the efficacy of DNA-based methods is
hampered due to nonspecific degradation by nucleases commonly present
in cancer cells and during preparations of cell lysates. In this report,
we describe a fluorescence-based assay using a specific and nuclease-resistant
three-dimensional DNAzyme walker to investigate the activity of DNA
glycosylases from cancer cell lysates. We focus on DNA glycosylases
that excise uracil from deoxyuridine (dU) lesions, namely, uracil
DNA glycosylase (UDG) and single-stranded monofunctional uracil DNA
glycosylase (SMUG1). The limits of detection for detecting UDG and
SMUG1 in the buffer were 3.2 and 3.0 pM, respectively. The DNAzyme
walker detected uracil excision activity in diluted cancer cell lysate
from as few as 48 A549 cells. The results of the UDG inhibitor experiments
demonstrate that UDG is the predominant uracil-excising glycosylase
in A549 cells. Approximately 500 nM of UDG is present in each A549
cell on average. No fluorescence was generated in the samples lacking
DNAzyme activation, indicating that there was no nonspecific nuclease
interference. The ability of the DNAzyme walker to respond to glycosylase
activity illustrates the potential use of DNAzyme walker technology
to monitor and study biochemical processes involving glycosylases.